
Overview
Antonella Verrienti practices in Rome, Italy. Ms. Verrienti is highly rated in 5 conditions, according to our data. Her top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Nodule, and Thyroidectomy.
Her clinical research consists of co-authoring 65 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Papillary Thyroid CancerMs. Verrienti isDistinguished. Learn about Papillary Thyroid Cancer.
- Thyroid CancerMs. Verrienti isDistinguished. Learn about Thyroid Cancer.
- Advanced
- Familial HDL DeficiencyMs. Verrienti isAdvanced. Learn about Familial HDL Deficiency.
- Medullary Thyroid CarcinomaMs. Verrienti isAdvanced. Learn about Medullary Thyroid Carcinoma.
- Thyroid NoduleMs. Verrienti isAdvanced. Learn about Thyroid Nodule.
- Experienced
- Adrenal CancerMs. Verrienti isExperienced. Learn about Adrenal Cancer.
- Anaplastic Thyroid CancerMs. Verrienti isExperienced. Learn about Anaplastic Thyroid Cancer.
- COVID-19Ms. Verrienti isExperienced. Learn about COVID-19.
- Familial Hyperthyroidism due to Mutations in TSH Receptor
- Follicular Thyroid CancerMs. Verrienti isExperienced. Learn about Follicular Thyroid Cancer.
- Generalized Resistance to Thyroid HormoneMs. Verrienti isExperienced. Learn about Generalized Resistance to Thyroid Hormone.